Table 2.
Characteristics of the patients with hypertension tested for COVID-19
| COVID-19 (−) | COVID-19 (+) | Difference (95% CI) | |
|---|---|---|---|
| Age | 80.6791*** | ||
| < 60 | 22,850 (0.97) | 665 (0.03) | |
| 61–69 | 15,609 (0.97) | 514 (0.03) | |
| 70–79 | 17,899 (0.98) | 418 (0.02) | |
| ≥ 80 | 17,258 (0.98) | 314 (0.02) | |
| Sex | 56.6345*** | ||
| Male | 38,922 (0.98) | 844 (0.02) | |
| Female | 34,694 (0.97) | 1067 (0.03) | |
| Diabetes Mellitus | 29.5498*** | ||
| Yes | 30,184 (0.97) | 902 (0.03) | |
| No | 43,432 (0.98) | 1009 (0.02) | |
| Cardiovascular disease | 2.9933 | ||
| Yes | 69,012 (0.97) | 1810 (0.03) | |
| No | 4604 (0.98) | 101 (0.02) | |
| Cerebrovascular disease | 26.7711*** | ||
| Yes | 59,392 (0.97) | 1632 (0.03) | |
| No | 14,224 (0.98) | 279 (0.02) | |
| Ischemic heart disease | 52.4329*** | ||
| Yes | 61,686 (0.97) | 1719 (0.03) | |
| No | 11,930 (0.98) | 192 (0.02) | |
| COPD | 53.0971*** | ||
| Yes | 68,791 (0.97) | 1865 (0.03) | |
| No | 4825 (0.99) | 46 (0.01) | |
| Malignancy | 180.4433*** | ||
| Yes | 59,384 (0.97) | 1775 (0.03) | |
| No | 14,232 (0.99) | 136 (0.01) | |
| Renal replacement therapy | 74.6484*** | ||
| Yes | 69,301 (0.97) | 1888 (0.03) | |
| No | 4315 (0.99) | 23 (0.01) | |
| ACEIs or ARBs | 0.0028 | ||
| Yes | 12,785 (0.97) | 331 (0.03) | |
| No | 60,831 (0.97) | 1580 (0.03) |
* P < .05; ** P < .01; *** P < .001